Cellectar Biosciences, Inc. Bonus & Incentive Agreements
17 Contracts & Agreements
- Cellectar Biosciences, Inc. 2021 Stock Incentive Plan, as Amended (Filed With SEC on June 29, 2023)
- Amendment 1 to the 2021 Stock Incentive Plan (Filed With SEC on June 27, 2022)
- 2021 Stock Incentive Plan (Filed With SEC on June 24, 2021)
- Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 25, 2020)
- Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 14, 2019)
- Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 1, 2018)
- RESTRICTED COMMON STOCK Granted by Cellectar Biosciences, Inc. (the“Company”) Under the 2015 Stock Incentive Plan (Filed With SEC on August 14, 2017)
- NON-STATUTORY STOCK OPTION Granted by Cellectar Biosciences, Inc.(the “Company”) Under the 2015 Stock Incentive Plan (Filed With SEC on August 12, 2015)
- Cellectar Biosciences, Inc. 2015 STOCK INCENTIVE PLAN (Filed With SEC on August 12, 2015)
- Novelos Therapeutics, Inc. AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN (Filed With SEC on December 18, 2013)
- Novelos Therapeutics, Inc. AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN (Filed With SEC on October 26, 2012)
- Novelos Therapeutics, Inc. AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN (Filed With SEC on May 23, 2011)
- Descriptionof Bonus Plan adopted on December8, 2009 (Filed With SEC on January 26, 2010)
- NovelosTherapeutics, Inc. 2006Stock Incentive Plan (asAmended November 3, 2009) (Filed With SEC on December 7, 2009)
- Form of Non-Statutory Director Stock Option under Novelos Therapeutics, Inc.s 2006 Stock Incentive Plan (Filed With SEC on December 15, 2006)
- Form of Non-Statutory Stock Option under Novelos Therapeutics, Inc.s 2006 Stock Incentive Plan (Filed With SEC on December 15, 2006)
- Form of Incentive Stock Option under Novelos Therapeutics, Inc.s 2006 Stock Incentive Plan (Filed With SEC on December 15, 2006)
